Hinge Health, Inc. logo

Hinge Health, Inc.(HNGE)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
5-STAR RATING
STRONG BUY
BUY for 67 days
PROFIT SINCE LAST BUY
+33.68% ▲
LAST CLOSE
$115.39
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for HNGE

11/13/2026: HNGE (5-star) is a STRONG-BUY. BUY for 67 days. Simulated Profits (33.68%). Updated daily EoD!

Hinge Health, Inc. is a health care technology company that provides digital musculoskeletal care solutions using wearable sensors and AI-driven motion tracking. The company has a leading position in the enterprise benefits market, backed by high gross margins and proven success in reducing employer medical costs. Its primary growth story centers on expanding specialized care programs like pelvic health and capturing greater market share among self-insured employers. However, risks include intense competition in digital health, enterprise budget sensitivity, and reliance on corporate sales cycles. The stock suits growth-oriented investors looking for digital health exposure, while key metrics to monitor include enterprise contract growth and operational profitability.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitHinge Health offers direct exposure to expanding digital health adoption and strong enterprise revenue growth.
Momentum investorStrong fit while signal remains positiveThe stock's strong post-IPO market performance makes it attractive during periods of positive price momentum.
Value investorWeak fitThe company trades at growth-oriented valuation multiples rather than traditional value metrics.
Dividend investorWeak fitHinge Health does not pay dividends, focusing entirely on capital appreciation and business scaling.
Low-risk investorMixed fitAs a relatively recent public health-tech company, it carries higher equity volatility than mature blue-chip stocks.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highGrowth-stage technology and healthcare stocks often experience sharp price swings based on market sentiment.
Valuation riskMedium / highHigher valuation multiples leave less room for error if revenue growth decelerates.
Competition risk (digital health and MSK rivals)Medium / highIntense rivalry from venture-backed startups and established telehealth providers could pressure pricing and market share.
Business qualityStrongThe company features high gross margins and strong product-market fit within self-insured corporate channels.
Dividend incomeLow / noneIncome-focused investors will receive no cash return from dividends.
Execution riskMediumSustained success depends on managing ongoing product expansions and hitting enterprise sales targets.

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 9.38B USD
Price to earnings Ratio 31.27
1Y Target Price 135.38
Price to earnings Ratio 31.27
1Y Target Price 135.38
Volume (30-day avg) 2.0M shares
Beta -
52 Weeks Range 30.08 - 126.40
Updated Date 11/15/2026
52 Weeks Range 30.08 - 126.40
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) 3.69

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Health Information Services

BUY participation
100.0%
Active BUY / eligible
4 / 4
30-Day BUY Count Change
+2

Eligible universe: 4 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 46.06%
Avg. Invested days 38
Today’s Advisory Strong Buy
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
HNGE receives a 3-star rating, supported by solid company fundamentals, and solid analyst coverage.

Company Fundamentals

★★★★★
HNGE has solid overall fundamentals (4 stars), with moderate financial health, moderate growth momentum, and solid ownership. In FY2025 versus FY2024, strong cash generation (FCF margin 29.0%) and strong revenue growth (+50.6%) are partially offset by negative earnings growth (-4326.9%), weak profitability (net margin -89.9%).

Financial Health Rating

★★★★★
HNGE's financial health is supported by solid liquidity, including working-capital and asset support (WC/assets 23.0%). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is HNGE's strongest growth driver at +277.5% FY2025 versus FY2024 (strong, 5 stars). By comparison, revenue growth (+50.6%, strong) is also strong, while earnings growth (-4326.9%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 99.8% and approximately 74.8% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 5.15% supports management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 4.39%
11.2 Capital Management, LLC 2.90%
Vanguard Portfolio Management, LLC 2.64%
Acadian Asset Management LLC 2.42%
Deer Management Co. LLC 2.35%

Unit Economics (Per $1K Revenue)

★★★★★
HNGE generates approximately $798 of gross profit, $-929 of operating income, and $290 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Weak margins and weak cash conversion support a 3-star rating, while capital efficiency is weak.

Economic Dimensions

★★★★★
Effective Tax Rate: -0.19% (Tax Credit)

Quantitative Style Profile

★★★★★
HNGE has a high-quality, liquid, relatively low-volatility profile. Soft valuation is the primary drawback.

Style Classification

Quality Focused

Quality TiltLow VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Enterprise Digital MSK PlatformSoftware-as-a-service (SaaS) and per-member-per-month (PMPM) subscription fees charged to self-insured employers and health plans.Hinge Health primarily earns recurring revenue by helping large organizations lower their overall employee healthcare costs.
Hardware and Connected DevicesBundled or standalone delivery of sensor kits and wearable pain relief units like Enso.Proprietary hardware tools enhance user engagement and clinical adherence to physical therapy programs.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2026-11-02
When After Market
Estimate 0.27
Actual 0.53

Profitability

Profit Margin 21.02%
Operating Margin (TTM) 18.75%

Management Effectiveness

Return on Assets (TTM) 11.42%
Return on Equity (TTM) 47.59%

Valuation

Trailing PE 31.27
Forward PE 37.45
Enterprise Value 9.12B
Price to Sales(TTM) 11.71
Enterprise Value 9.12B
Price to Sales(TTM) 11.71
Enterprise Value to Revenue 11.38
Enterprise Value to EBITDA 58.53
Shares Outstanding 68.49M
Shares Floating 51.24M
Shares Outstanding 68.49M
Shares Floating 51.24M
Percent Insiders 5.15
Percent Institutions 99.81

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.